MOTS-c vs AOD-9604: Which Is Better for Metabolic Signaling Research?
Last updated:
MOTS-c vs AOD-9604 is a growing comparison in metabolic peptide research, contrasting intracellular mitochondrial AMPK signaling against peripheral adipose tissue lipolysis via beta-3 adrenergic receptor pathways.
MOTS-c vs AOD-9604: Quick Answer
MOTS-c is preferred for mitochondrial function and AMPK pathway studies, while AOD-9604 is used for research specifically targeting adipose lipolysis without GH receptor activation.
Choose MOTS-c for:
- →AMPK pathway activation and mitochondrial biogenesis studies
- →Glucose uptake and insulin sensitivity research
- →Intracellular metabolic stress signaling models
Choose AOD-9604 for:
- →Adipose tissue lipolysis without GH receptor binding
- →GH-independent fat metabolism pathway studies
- →Beta-3 adrenergic receptor research in adipose models
This guide compares MOTS-c vs AOD-9604, also searched as AOD-9604 vs MOTS-c, to help researchers identify the right compound for their specific metabolic pathway endpoints.
MOTS-c vs AOD-9604 is an emerging comparison in metabolic peptide research. MOTS-c is investigated for AMPK activation and mitochondrial biogenesis; AOD-9604 is studied for lipolytic signaling and adipose tissue metabolism without GH receptor binding. For the reverse comparison, see AOD-9604 vs MOTS-c for lipolytic pathway context. For the broader metabolic landscape, see best peptides for metabolic research.
Key Differences at a Glance
- →MOTS-c is a mitochondria-derived peptide (MDP); AOD-9604 is a C-terminal fragment of human growth hormone
- →MOTS-c is studied for AMPK activation and mitochondrial function; AOD-9604 for lipolytic signaling
- →Both are 16 amino acids in length but are structurally and mechanistically distinct
- →AOD-9604 does not bind the GH receptor in research models — a key distinguishing feature
- →MOTS-c research focuses on glucose metabolism and insulin sensitivity; AOD-9604 on adipose tissue lipolysis
MOTS-c and AOD-9604 are both investigated in metabolic research but represent fundamentally different classes of compounds. MOTS-c is a mitochondrial peptide with AMPK-linked activity, while AOD-9604 is a GH-derived fragment studied for lipolytic signaling. For all metabolic comparisons, see the peptide comparisons hub.
MOTS-c vs AOD-9604: At a Glance
| Characteristic | MOTS-c | AOD-9604 |
|---|---|---|
| Peptide Class | Mitochondria-derived peptide (MDP) | Fragment of human growth hormone (hGH 176-191) |
| Origin | Encoded in mitochondrial 12S rRNA | C-terminal fragment of human GH |
| Amino Acids | 16 amino acids | 16 amino acids |
| Primary Research Focus | Mitochondrial function, metabolic signaling, AMPK activation | Lipolytic signaling, fat metabolism, adipose tissue research |
| Metabolic Pathway | AMPK activation, glucose metabolism | Beta-3 adrenergic receptor stimulation, lipolysis |
| GH Receptor Interaction | No GH receptor binding studied | Does not bind GH receptor in research models |
| Insulin Sensitivity Research | Investigated in animal models | No direct insulin sensitivity research noted |
| Mitochondrial Research | Primary area of investigation | Not directly investigated |
| Lipolysis Research | Secondary area | Primary area of investigation |
| Half-Life | Short; specific values under study | Short; specific values under study |
Recommended for this research
MOTS-c
Research-grade · HPLC verified · Certificate of Analysis included
Why Researchers Compare MOTS-c and AOD-9604
MOTS-c and AOD-9604 are compared in metabolic peptide research because both are investigated for their roles in energy and fat metabolism, yet they operate through entirely different mechanisms and originate from distinct biological sources. Research suggests MOTS-c acts as an intracellular signaling molecule that activates the AMPK pathway — a key regulator of cellular energy homeostasis — while AOD-9604 is studied for its ability to stimulate lipolysis in adipose tissue through beta-3 adrenergic receptor pathways.
The comparison is particularly relevant to researchers studying obesity models, metabolic syndrome pathways, and mitochondrial function. Studies indicate MOTS-c may influence insulin sensitivity and glucose uptake in skeletal muscle models, while AOD-9604 is investigated in adipose tissue models for fat mobilization without the anabolic signaling associated with full-length growth hormone.
MOTS-c: Research Overview
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid peptide encoded within the mitochondrial genome — specifically within the 12S rRNA gene. It is classified as a mitochondria-derived peptide (MDP) and represents a novel class of signaling molecules investigated for their role in metabolic regulation and cellular energy homeostasis.
Laboratory research has investigated MOTS-c for its activation of the AMPK (AMP-activated protein kinase) pathway, a central regulator of cellular energy sensing. Studies indicate MOTS-c may improve glucose uptake in skeletal muscle cells and is studied in models of metabolic stress, insulin resistance, and mitochondrial biogenesis. Its mitochondrial origin makes it a unique subject in metabolic peptide research.
AOD-9604: Research Overview
AOD-9604 is a 16-amino acid fragment corresponding to the C-terminal region (amino acids 176–191) of human growth hormone. It is investigated in laboratory research for lipolytic signaling — the process by which fat cells release stored fatty acids. Research suggests AOD-9604 stimulates beta-3 adrenergic receptors in adipose tissue, triggering lipolysis without activating the GH receptor.
A key characteristic in AOD-9604 research is its apparent lack of GH receptor binding, which distinguishes its activity profile from full-length growth hormone. Studies indicate this property may allow for isolated investigation of GH-independent lipolytic pathways. AOD-9604 has been studied in animal models of obesity and fat metabolism, though research is ongoing.
Research Summary
MOTS-c is a mitochondria-derived peptide (MDP) investigated for AMPK activation, mitochondrial function, and glucose metabolism. AOD-9604 is a GH C-terminal fragment studied for lipolytic signaling via beta-3 adrenergic receptors without GH receptor binding. For the complementary perspective, see AOD-9604 vs MOTS-c for lipolytic pathway context. For broader metabolic peptide research, see best peptides for metabolic research. Both compounds are for laboratory research only and are not approved for human consumption.
Which Is Better for Specific Research Goals?
MOTS-c and AOD-9604 serve fundamentally different research purposes. For longevity-oriented metabolic research, MOTS-c's mitochondrial signaling is a strong area of study; for GH-independent fat metabolism endpoints, AOD-9604 is the clearer choice. Researchers investigating the full metabolic peptide landscape may also find the best peptides for longevity research guide and the best peptides for fat loss and metabolic health research useful reference pages.
Fat Loss / Lipolysis Research
AOD-9604 — specifically investigated for beta-3 adrenergic receptor-mediated lipolysis in adipose tissue without GH receptor binding. The direct adipose tissue targeting makes it the preferred compound when the study endpoint is fat mobilization via a GH-independent pathway.
Mitochondrial Function and Energy Metabolism
MOTS-c — as a mitochondria-derived peptide, MOTS-c is the primary compound for studying AMPK activation, mitochondrial biogenesis, and cellular energy sensing. It is the only compound in this comparison with a direct intracellular mitochondrial research profile.
Longevity and Cellular Aging Research
MOTS-c — mitochondrial function is closely studied in the context of cellular aging. MOTS-c's AMPK pathway activation and role in cellular energy homeostasis make it more relevant to longevity-oriented research than AOD-9604, which is focused on adipose lipolysis rather than aging mechanisms.
Insulin Sensitivity Research
MOTS-c — investigated in animal models for glucose uptake and insulin sensitivity via AMPK pathways in skeletal muscle. AOD-9604 has no direct insulin sensitivity research profile, making MOTS-c the clear choice for studies examining glucose metabolism and insulin signaling endpoints.
Best Use Cases
MOTS-c is best for:
- →AMPK pathway activation and cellular energy sensing
- →Mitochondrial biogenesis and function studies
- →Glucose uptake and insulin sensitivity models
- →Mitochondria-derived peptide (MDP) class research
AOD-9604 is best for:
- →Adipose tissue lipolysis via beta-3 adrenergic pathways
- →GH-independent fat mobilization without IGF-1 axis effects
- →Adipocyte biology and fat metabolism without GHR binding
- →GH fragment SAR studies vs. full-length growth hormone
Which Is Better Overall?
Neither is universally better — MOTS-c targets intracellular mitochondrial signaling, AOD-9604 targets peripheral adipose tissue. Choice depends entirely on whether the study endpoint is AMPK/glucose or lipolysis.
The better choice depends on the research objective:
- →AMPK activation and mitochondrial function study → MOTS-c
- →Adipose tissue lipolysis research → AOD-9604
- →Glucose metabolism and insulin sensitivity → MOTS-c
- →GH-independent fat mobilization pathway → AOD-9604
Related Comparisons
Related Research Articles
Expand Your Research Toolkit
Frequently Asked Questions
What is the difference between MOTS-c and AOD-9604?
Does AOD-9604 bind to growth hormone receptors?
What is MOTS-c studied for?
Are MOTS-c and AOD-9604 both metabolic peptides?
What does mitochondria-derived peptide mean?
Trust OmegaCore for Research-Grade Compounds
OmegaCore Research provides pharmaceutical-grade peptides independently verified through HPLC analysis. Every batch includes a Certificate of Analysis documenting purity, sequence confirmation, and handling specifications.
View Research Compounds →Research Use Only
This content is for educational and informational purposes within the research community. MOTS-c and AOD-9604 are intended for laboratory research use only and are not approved for human consumption. All handling must be conducted by trained personnel in appropriate laboratory settings in compliance with applicable regulations.